While our study demonstrated the significant implications for the radioresistance of NSCLC treatment, further investigations are required to elucidate the underlying mechanism mediating the interaction among miR-320a, HIF1α, KDM5B, and PTEN in NSCLC. The gene discussed is KDM5B; the disease is non-small cell lung carcinoma.